IP Library Granted Patent US 6,913,588
Granted Patent B2
US 6,913,588 · App. 10/402,912 · Granted Jul 5, 2005

Extracorporeal fluid circuit and related methods

Assignees: Nephros Therapeutics, Inc.; The Regents of the University of Michigan
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,913,588
App. No.
10/402,912
Granted
Jul 5, 2005
Kind
B2
Abstract

A circuit for extracorporeal treatment of a body fluid, the circuit including in serial fluidic communication an inlet for receiving the body fluid from a patient, a first pump, a first treatment device for processing the body fluid, a second pump, an outlet for returning processed body fluid to the patient; and a shunt. The shunt is upstream from the first pump and downstream from the second pump.

Claims (32)

1. A circuit for extracorporeal treatment of a fluid from a body, the circuit comprising:

(a) a first section comprising in serial fluidic communication:

(1) an inlet for receiving a body fluid from a source;

(2) a first treatment device for processing the body fluid;

(3) a first pump;

(4) an outlet for providing processed body fluid to the body; and

(5) a shunt, wherein the shunt connects the inlet with the outlet; and

(b) a second section comprising in serial fluidic communication:

(1) a first conduit for receiving an additional fluid from the source;

(2) a second pump; and

(3) the first treatment device for processing the additional fluid, wherein the first treatment device comprises a porous member capable of permitting at least a portion of the additional fluid to combine with at least a portion of the body fluid,

wherein the porous member has a cell located adjacent thereto; and

wherein the circuit further comprises a third pump between the inlet and the first treatment device in the first section or a third pump after the first treatment device in the second section.

2. The circuit of claim 1 wherein the body fluid is altered prior to entering the inlet.

3. The circuit of claim 1 wherein the shunt connects the inlet to the outlet.

4. The circuit of claim 1 wherein the source comprises a second treatment device and the circuit further comprises the second treatment device upstream from the inlet.

5. The circuit of claim 1 wherein the first treatment device performs at least one function of a human organ.

6. The circuit of claim 5 wherein the first treatment device comprises a renal assist device.

7. The circuit of claim 1 wherein the shunt is in parallel with the first treatment device.

8. The circuit of claim 1 wherein at least a portion of the additional fluid receivable within the first conduit and at least a portion of the body fluid receivable within the inlet combine within the first treatment device.

9. The circuit of claim 1 wherein at least one of the fluids is altered within the first treatment device.

10. The circuit of claim 1 further comprising a waste receptacle in fluidic communication with the first treatment device.

11. The circuit of claim 1 further comprising at least one heating device in association with the circuit.

12. The circuit of claim 1 further comprising an anticoagulant infuser in fluidic communication with the circuit.

13. The circuit of claim 1 wherein at least one of the pumps has a pumping rate from about 10 ml/mm to about 1000 ml/mm.

14. The circuit of claim 1 wherein the first pump has a pumping rate that differs from a pumping rate of the third pump by a value ranging from about 1 ml/min to about 200 ml/min.

15. The circuit of claim 1 wherein the third pump is after the first treatment device in the second section.

16. The circuit of claim 15 further comprising a flow controller between the inlet and the first treatment device in the first section.

17. The circuit of claim 16 wherein the flow controller comprises a pump.

18. The circuit of claim 16 wherein the flow controller comprises a clamp.

19. The circuit of claim 16 wherein the flow controller comprises a pressure monitor.

20. The circuit of claim 1 wherein the body fluid comprises filtered blood.

Assignments (9)
CONFIRMATORY LICENSE Recorded Jan 14, 2021
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 054920/0088 →
CONFIRMATORY LICENSE Recorded Nov 11, 2018
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047468/0303 →
CHANGE OF NAME Recorded Dec 2, 2009
From: NEPHRION, INC.
To: CYTOPHERX, INC.
Reel/Frame 023586/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2007
From: RENAMED BIOLOGICS, INC.
To: NEPHRION, INC.
Reel/Frame 019899/0330 →
MERGER Recorded May 3, 2006
From: NEPHROS THERAPEUTICS, INC. (MICHIGAN CORPORATION)
To: NEPHROS THERAPEUTICS, INC. (DELAWARE CORPORATION)
Reel/Frame 017564/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2006
From: WEITZEL, WILLIAM FREDERICK; PAGANINI, EMIL PRESLEY; BUFFINGTON, DEBORAH ANN; FUNKE, ANGELA J.
To: NEPHROS THERAPEUTICS, INC. (MICHIGAN CORPORATION)
Reel/Frame 017564/0096 →
CHANGE OF NAME Recorded May 3, 2006
From: NEPHROS THERAPEUTICS, INC. (DELAWARE CORPORATION)
To: RENAMED BIOLOGICS, INC.
Reel/Frame 017564/0101 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2004
From: WEITZEL, WILLIAM FREDERICK; PAGANINI, EMIL PRESLEY; BUFFINGTON, DEBORAH ANN; WESTOVER, ANGELA J. (NEE FUNKE)
To: NEPHROS THERAPEUTICS, INC.
Reel/Frame 014916/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2004
From: HUMES, H. DAVID
To: MICHIGAN, UNIVERSITY OF, REGENTS OF THE, THE
Reel/Frame 014933/0986 →
Continuity (3)
Continuation 0955372200 · Apr 21, 2000
Provisional Application 6013068800 · Apr 23, 1999
Related Publication 20040024342A1 · Feb 5, 2004